New UK Clinical Trials Regulation 2024: What You Need to Know
Published May 29, 2025
Published 02nd October 2023
In the domain of Pharmaceutical Regulatory Affairs, regulatory agencies such as EMA and FDA are harnessing the potential of Artifical Intelligence (AI) to revolutionise assessment and oversight. While EMA and FDA are in consultation with stakeholders, we explore AI’s transformative impact and potential challenges ahead. AI enables machines to learn, think, and perform human like tasks, particularly excelling in data analysis and decision making.
Published May 29, 2025
Published May 29, 2025
Published May 01, 2025
Published Apr 28, 2025
Published Apr 25, 2025
Published Apr 11, 2025
Published Mar 31, 2025
Published Mar 27, 2025
Published Mar 27, 2025